UIH(SH:688271) Sou Hu Cai Jing·2025-09-21 17:00Core Viewpoint - The report indicates that United Imaging Healthcare (688271) has shown stable financial performance in the first half of 2025, with significant growth in revenue and overseas income, while maintaining compliance in fund usage and corporate governance [1][3]. Trading Information Summary - On September 19, 2025, United Imaging Healthcare's stock closed at 147.9 yuan, down 1.4%, with a turnover rate of 0.82%, trading volume of 67,400 shares, and a total transaction value of 1.005 billion yuan [1]. - On the same day, the net outflow of main funds was 90.38 million yuan, accounting for 8.99% of the total transaction value; retail investors had a net inflow of 42.42 million yuan, representing 4.22% of the total transaction value [1]. Company Announcement Summary - United Imaging Healthcare reported a revenue of 6.016 billion yuan for the first half of 2025, reflecting a year-on-year growth of 12.79%; the net profit attributable to shareholders was 999.8 million yuan, up 5.03% year-on-year [1][3]. - The company's overseas revenue reached 1.142 billion yuan, marking a year-on-year increase of 22.48% [1][3]. - Research and development (R&D) expenditures totaled 1.14 billion yuan, with capitalized R&D investments increasing by 95.56% year-on-year [1][3]. - The report from the sponsors, CITIC Securities and CICC, indicated no significant issues or violations during the reporting period, and the core competitiveness of the company remained stable [1].